Showing results (31-40 of 6,003) with videos related to

Sort By:
Pageof 601
Molecular Cancer Therapeutics|September 30, 2010
Efficacy of the multi-kinase inhibitor enzastaurin is dependent on cellular signaling contextWen-Liang Kuo, Jing Liu, Helena Mauceri, et al.
Molecular Cancer Therapeutics|August 19, 2010
Urokinase plasminogen activator receptor and/or matrix metalloproteinase-9 inhibition induces apoptosis signaling through lipid rafts in glioblastoma xenograft cellsChandramu Chetty, Sajani S Lakka, Praveen Bhoopathi, et al.
Molecular Cancer Therapeutics|August 19, 2010
From NPC therapeutic target identification to potential treatment strategyMing-Ying Lan, Chi-Long Chen, Kuan-Ting Lin, et al.
Molecular Cancer Therapeutics|August 7, 2010
Phase I safety, pharmacokinetic, and biomarker study of BIBF 1120, an oral triple tyrosine kinase inhibitor in patients with advanced solid tumorsIsamu Okamoto, Hiroyasu Kaneda, Taroh Satoh, et al.
Molecular Cancer Therapeutics|June 24, 2010
The dynamin inhibitors MiTMAB and OcTMAB induce cytokinesis failure and inhibit cell proliferation in human cancer cellsSanket Joshi, Swetha Perera, Jayne Gilbert, et al.
Molecular Cancer Therapeutics|September 7, 2010
Real-time fluorescent resonance energy transfer analysis to monitor drug resistance in chronic myelogenous leukemiaAhmet Tunceroglu, Michiyuki Matsuda, Raymond B Birge
Molecular Cancer Therapeutics|September 11, 2010
A microRNA screen to identify modulators of sensitivity to BCL2 inhibitor ABT-263 (navitoclax)Lloyd T Lam, Xin Lu, Haichao Zhang, et al.
Molecular Cancer Therapeutics|July 28, 2010
A combination of DR5 agonistic monoclonal antibody with gemcitabine targets pancreatic cancer stem cells and results in long-term disease control in human pancreatic cancer modelN V Rajeshkumar, Zeshaan A Rasheed, Elena García-García, et al.
Molecular Cancer Therapeutics|July 22, 2010
A review of trabectedin (ET-743): a unique mechanism of actionMaurizio D'Incalci, Carlos M Galmarini
Molecular Cancer Therapeutics|August 5, 2010
Combinations of DNA methyltransferase and histone deacetylase inhibitors induce DNA damage in small cell lung cancer cells: correlation of resistance with IFN-stimulated gene expressionWioleta Luszczek, Venugopalan Cheriyath, Tarek M Mekhail, et al.
Pageof 601